Serum lipid levels in women with premature ovarian failure

Menopause

Volumn 19, Issue 11, 2012, Pages 1231-1234

  Gulhan, Ibrahim ^a   Bozkaya, Giray ^a   Uyar, Ibrahim ^b   Oztekin, Deniz ^b   Pamuk, Baris Onder ^a   Dogan, Erbil ^c  

^a Izmir Bozyaka Research Hospital   (Turkey)

^b Ege Maternity and Gynecology Training and Research Hospital   (Turkey)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Estrogen deprivation; Lipid profile; Premature ovarian failure

Indexed keywords

CHOLESTEROL; ESTRADIOL; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; PROGESTERONE; SEX HORMONE; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; PREMATURE OVARIAN FAILURE; PROGESTERONE BLOOD LEVEL; SMOKING; TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BODY MASS INDEX; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; LIPIDS; PRIMARY OVARIAN INSUFFICIENCY; PROGESTERONE; TESTOSTERONE; TRIGLYCERIDES;

EID: 84868706471     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e318254102b     Document Type: Article

References (22)

1. Hjortland MC, McNamara PM, Kannel WB. Some atherogenic concomitants of menopause: the Framingham Study. Am J Epidemiol 1976; 103:304-311.
2. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993;98:83-90. (Pubitemid 23010426)
3. Ushiroyama T, Okamoto Y, Sugimoto O. Plasma lipid and lipoprotein levels in perimenopausal women. Clinical research in 1198 Japanese women. Acta Obstet Gynecol Scand 1993;72:428-433. (Pubitemid 23235293)
4. Do KA, Green A, Guthrie JR, Dudley EC, Burger HG, Dennerstein L. Longitudinal study of risk factors for coronary heart disease across the menopausal transition. Am J Epidemiol 2000;151:584-593. (Pubitemid 30463603)
5. Torng PL, Su TC, Sung FC, et al. Effects of menopause on intra-individual changes in serum lipids, blood pressure, and body weight: the Chin-Shan Community Cardiovascular Cohort study. Atherosclerosis 2002;161:409-415. (Pubitemid 34219195)
6. Graff-Iversen S, Thelle DS, Hammar N. Serum lipids, blood pressure and body weight around the age of the menopause. Eur J Cardiovasc Prev Rehabil 2008;15:83-88. (Pubitemid 351263260)
7. The Writing Group on behalf of the Workshop Consensus Group. Aging, menopause, cardiovascular disease and HRT. Climacteric 2009;12: 368-377.
8. Grodstein F, Manson JE, Stampfer MJ. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health 2006;15:35-44. (Pubitemid 43192860)
9. Kalu E, Panay N. Spontaneous premature ovarian failure: management challenges. Gynecol Endocrinol 2008;24:273-279. (Pubitemid 351891657)
10. Albright F, Smith P, Fraser R. A syndrome characterized by primary ovarian insufficiency and decreased stature. Am J Med Sci 1942;204: 625-648.
11. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, Rocca WA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010;65:161-166.
12. Rivera CM, Grossardt BR, Rhodes DJ, et al. Increased cardiovascular mortality after early bilateral oophorectomy. Menopause 2009;16:15-23.
13. Rocca WA, Grossardt BR, de Andrade M, Malkasian GD, Melton LJ 3rd. Survival patterns after oophorectomy in premenopausal women: A population-based cohort study. Lancet Oncol 2006;7:821-828. (Pubitemid 44464065)
14. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravinkar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991;325: 1196-1204.
15. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208.
16. Grodstein F, Manson JE, Colditz GA, Willett WC, Speizer FE, Stampfer MJ. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med 2000;133:933-941. (Pubitemid 32003509)
17. Kalantaridou SN, Naka KK, Papanikolaou E, et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J Clin Endocrinol Metab 2004;89:3907-3913. (Pubitemid 39071493)
18. Knauff EA, Westerveld HE, Goverde AJ, et al. Lipid profile of women with premature ovarian failure. Menopause 2008;15:919-923.
19. Chu MC, Rath KM, Huie J, Taylor HS. Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk. Hum Reprod 2003;18:1570-1573. (Pubitemid 36958032)
20. Kim CJ, Kim TH, Ryu WS, Ryoo UH. Influence of menopause on high density lipoprotein-cholesterol and lipids. J Korean Med Sci 2000;15: 380-386.
21. Berg G, Mesch V, Boero L, et al. Lipid and lipoprotein profile in men-opausal transition. Effects of hormones, age and fat distribution. Horm Metab Res 2004;36:215-220. (Pubitemid 38626408)
22. Cho EJ, Min YJ, Oh MS, et al. Effects of the transition from pre-menopause to postmenopause on lipids and lipoproteins: quantification and related parameters. Korean J Intern Med 2011;26:47-53.